HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ravi P Sahu Selected Research

platelet activating factor receptor

6/2022Effects of miRNA-149-5p and Platelet-Activating Factor-Receptor Signaling on the Growth and Targeted Therapy Response on Lung Cancer Cells.
11/2020Platelet-Activating Factor-Receptor Signaling Mediates Targeted Therapies-Induced Microvesicle Particles Release in Lung Cancer Cells.
12/2018Gemcitabine Induces Microvesicle Particle Release in a Platelet-Activating Factor-Receptor-Dependent Manner via Modulation of the MAPK Pathway in Pancreatic Cancer Cells.
10/2018Systemic Platelet-Activating Factor-Receptor Agonism Enhances Non-Melanoma Skin Cancer Growth.
7/2017Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathway.
1/2015Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.
1/2014Platelet-Activating Factor-Receptor and Tumor Immunity.
1/2014Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis.
1/2014Topical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skin.
3/2012Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ravi P Sahu Research Topics

Disease

34Neoplasms (Cancer)
06/2022 - 10/2008
11Melanoma (Melanoma, Malignant)
12/2019 - 07/2012
10Pancreatic Neoplasms (Pancreatic Cancer)
07/2020 - 10/2008
9Carcinogenesis
11/2021 - 03/2012
6Inflammation (Inflammations)
10/2018 - 01/2012
5Neoplasm Metastasis (Metastasis)
07/2020 - 01/2011
4Skin Neoplasms (Skin Cancer)
11/2021 - 10/2018
2Lung Neoplasms (Lung Cancer)
06/2022 - 11/2020
2Edema (Dropsy)
09/2019 - 01/2014
2Experimental Melanoma
07/2017 - 01/2015
2Contact Dermatitis (Eczema, Contact)
03/2013 - 03/2012
1Breast Neoplasms (Breast Cancer)
01/2022
1Disease Progression
01/2022
1Hypoxia (Hypoxemia)
09/2021
1Triple Negative Breast Neoplasms
02/2021
1Pathologic Processes
01/2021
1COVID-19
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2019
1Burns
11/2018
1Pigmented Nevus (Melanocytic Nevus)
10/2018
1Otitis
01/2014
1Hyperemia
01/2013

Drug/Important Bio-Agent (IBA)

10platelet activating factor receptorIBA
06/2022 - 03/2012
6LipidsIBA
01/2021 - 01/2014
6Platelet Activating FactorIBA
01/2021 - 03/2012
6AntioxidantsIBA
07/2020 - 07/2012
51-O-hexadecyl-2-N-methylcarbamol -sn-glycerol-3-phosphocholineIBA
06/2022 - 07/2012
5benzyl isothiocyanateIBA
01/2011 - 02/2009
4Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2008
4Caspase 3 (Caspase-3)IBA
10/2012 - 05/2007
3CarcinogensIBA
01/2021 - 03/2012
3anthraceneIBA
10/2018 - 03/2012
3phorbolIBA
10/2018 - 03/2012
3LigandsIBA
11/2017 - 05/2007
2GTP-Binding Proteins (G-Protein)IBA
06/2022 - 11/2020
2MicroRNAs (MicroRNA)IBA
06/2022 - 12/2019
2PhytochemicalsIBA
02/2021 - 07/2020
2Reactive Oxygen Species (Oxygen Radicals)IBA
07/2020 - 10/2009
2Rosiglitazone (Avandia)FDA Link
06/2019 - 11/2017
2Biological ProductsIBA
01/2019 - 01/2014
2GemcitabineFDA Link
12/2018 - 01/2017
2ProstaglandinsIBA
07/2017 - 01/2017
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2017 - 01/2017
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
07/2017 - 01/2017
2EnzymesIBA
01/2017 - 03/2013
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
04/2016 - 12/2014
2Phorbol EstersIBA
01/2014 - 03/2012
2SmokeIBA
01/2014 - 03/2013
2AntibodiesIBA
07/2012 - 07/2007
2AntigensIBA
03/2012 - 07/2007
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2011 - 05/2007
1Monoclonal AntibodiesIBA
01/2022
1tucatinibIBA
01/2022
1Tyrosine Kinase InhibitorsIBA
01/2022
1human ERBB2 proteinIBA
01/2022
1Insulin-Like Growth Factor I (IGF-1)IBA
11/2021
11-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2021
1Tretinoin (Retinoic Acid)FDA LinkGeneric
09/2021
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
09/2021
1Aminolevulinic Acid (Levulan)FDA Link
09/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2021
1withaferin AIBA
02/2021
1Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2020
1Gefitinib (Iressa)FDA Link
11/2020
1PolyphenolsIBA
07/2020
1Biomarkers (Surrogate Marker)IBA
12/2019
1Immunologic Factors (Immunomodulators)IBA
10/2019
1CarrageenanIBA
09/2019
1HMGB1 Protein (HMG1)IBA
01/2019
1Immune Checkpoint ProteinsIBA
01/2019
1CytokinesIBA
11/2018
1Ethanol (Ethyl Alcohol)IBA
11/2018
1Interleukin-6 (Interleukin 6)IBA
11/2018
1Acetates (Acetic Acid Esters)FDA Link
10/2018
1Myristic Acid (Tetradecanoic Acid)IBA
10/2018
1Fibroblast Growth Factor 1 (FGF-1)IBA
07/2017
1Pharmaceutical PreparationsIBA
07/2017
1Arachidonic Acid (Vitamin F)IBA
01/2017
1Antineoplastic Agents (Antineoplastics)IBA
01/2017
1NucleosidesIBA
01/2017
1Etoposide (VP 16)FDA LinkGeneric
01/2015
1Chloroquine (Aralen)FDA LinkGeneric
09/2013
1Peptide Hydrolases (Proteases)FDA Link
09/2013
1HydrolasesIBA
03/2013
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2013
1Celecoxib (Celebrex)FDA Link
01/2013
1PPAR gammaIBA
10/2012
12-chloro-5-nitrobenzanilideIBA
10/2012
1Interleukin-10 (Interleukin 10)IBA
07/2012
1Peroxidase (Myeloperoxidase)IBA
03/2012
1DinitrofluorobenzeneIBA
03/2012

Therapy/Procedure

8Therapeutics
06/2022 - 01/2017
5Drug Therapy (Chemotherapy)
12/2018 - 02/2011
2Immunotherapy
01/2022 - 12/2011
2Aftercare (After-Treatment)
01/2022 - 10/2012
2Chemoprevention
02/2021 - 07/2020
1Photochemotherapy (Photodynamic Therapy)
09/2021
1Immunomodulation
01/2018
1Radiotherapy
04/2016